European Equities Traded in US as American Depositary Receipts Rise Friday, Poised to End Week Lower

European equities traded in the US as American depositary receipts rose Friday morning, gaining 0.61% to 1,418.20 on the S&P Europe Select ADR Index. The index is poised to end the week lower.

From continental Europe, the gainers were led by biotech firm BioNTech (BNTX) and pharmaceutical company Ascendis Pharma (ASND), which rose 4% and 3.5% respectively. They were followed by biopharmaceutical company Cellectis (CLLS) and oil and gas company TotalEnergies (TTE), which increased 3.3% and 2.2% respectively.

The decliners from continental Europe were led by biopharmaceutical companies Genfit (GNFT) and DBV Technologies (DBVT), which fell 14% and 5.3% respectively. They were followed by semiconductor company Sequans Communications (SQNS) and hotel booking site trivago (TRVG), which dropped 3.4% and 2.3% respectively.

From the UK and Ireland, the gainers were led by biopharmaceutical companies Adaptimmune Therapeutics (ADAP) and Verona Pharma (VRNA), which climbed 10% and 6.5% respectively. They were followed by biopharmaceutical company Biodexa Pharmaceuticals (BDRX) and biotech firm Trinity Biotech (TRIB), which were up 4.1% and 3.6% respectively.

The decliners from the UK and Ireland were led by biopharmaceutical company NuCana (NCNA) and construction materials supplier CRH (CRH), which lost 2.4% and 2.1% respectively. They were followed by gas and electricity provider National Grid (NGG) and biopharmaceutical company Akari Therapeutics (AKTX), which were down 1.3% and 0.9% respectively.